RT Journal Article
SR Electronic
T1 Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 144
OP 150
DO 10.2967/jnumed.115.158915
VO 57
IS 1
A1 Rosenthal, Eben L.
A1 Warram, Jason M.
A1 de Boer, Esther
A1 Basilion, James P.
A1 Biel, Merrill A.
A1 Bogyo, Matthew
A1 Bouvet, Michael
A1 Brigman, Brian E.
A1 Colson, Yolonda L.
A1 DeMeester, Steven R.
A1 Gurtner, Geoffrey C.
A1 Ishizawa, Takeaki
A1 Jacobs, Paula M.
A1 Keereweer, Stijn
A1 Liao, Joseph C.
A1 Nguyen, Quyen T.
A1 Olson, James M.
A1 Paulsen, Keith D.
A1 Rieves, Dwaine
A1 Sumer, Baran D.
A1 Tweedle, Michael F.
A1 Vahrmeijer, Alexander L.
A1 Weichert, Jamey P.
A1 Wilson, Brian C.
A1 Zenn, Michael R.
A1 Zinn, Kurt R.
A1 van Dam, Gooitzen M.
YR 2016
UL http://jnm.snmjournals.org/content/57/1/144.abstract
AB Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to improve the efficacy of oncologic surgery. To achieve routine clinical use, the onus is on the surgical community to objectively assess the value of this technique. This assessment may facilitate both Food and Drug Administration approval of new optical imaging agents and reimbursement for the imaging procedures. It is critical to characterize fluorescence-guided procedural benefits over existing practices and to elucidate both the costs and the safety risks. This report is the result of a meeting of the International Society of Image Guided Surgery (www.isigs.org) on February 6, 2015, in Miami, Florida, and reflects a consensus of the participants’ opinions. Our objective was to critically evaluate the imaging platform technology and optical imaging agents and to make recommendations for successful clinical trial development of this highly promising approach in oncologic surgery.